Literature DB >> 23122348

CT imaging: radiation risk reduction--real-life experience in a metropolitan outpatient imaging network.

John O Johnson1, Jon M Robins.   

Abstract

The exponential growth of CT imaging has been fueled by recent technical advances, improved diagnostic accuracy, and medicolegal pressures. CT imaging has replaced many more invasive and expensive tests and has proven itself an indispensable part of diagnostic medicine. This growth in CT imaging, however, has also been accompanied by an unavoidable increased cumulative radiation exposure to the general public. It is important to fully understand the risks and benefits of and alternatives to CT imaging so that an informed decision can be made. A number of simple strategies may be used to minimize radiation exposure during CT imaging. These include protocol redesign and CT dose adjustments on the basis of each patient's body mass index, limiting length of coverage and multiphase examinations, and iterative reconstruction. At Imaging Healthcare Specialists, a highly successful program of radiation dose reduction was created, and dose savings of up to 90% have been achieved in select patients while maintaining diagnostic image quality. The approach is simple, reproducible, and inexpensive.
Copyright © 2012 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23122348     DOI: 10.1016/j.jacr.2012.06.026

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  2 in total

1.  Assessment of radiation dose from abdominal quantitative CT with short scan length.

Authors:  Xinhua Li; Kai Yang; Matthew C DeLorenzo; Bob Liu
Journal:  Br J Radiol       Date:  2017-05-23       Impact factor: 3.039

2.  The quality/safety medical index: a standardized method for concurrent optimization of radiation dose and image quality in medical imaging.

Authors:  Bruce I Reiner
Journal:  J Digit Imaging       Date:  2014-12       Impact factor: 4.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.